tradingkey.logo
tradingkey.logo
Search

Abeona Therapeutics Inc

ABEO
Add to Watchlist
5.430USD
-0.100-1.81%
Close 09-24 16:00(ET)
309.51MMarket Cap
4.24P/E TTM

ABEO Financials

See Abeona Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
309.51M
Dividend TTM
0.00
P/E TTM
4.24
EPS TTM
1.28
Revenue
5.82M
Net Profit
-63.73M
ROE
70.99%
ROA
44.41%

Abeona Therapeutics Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.35/-0.23
Revenue / Forecast
11.38M/12.24M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-117.08%-0.35
-24.80%-0.30
-94.10%-0.37
84.89%-0.10
1019.42%2.07
79.10%-0.24
70.44%-0.19
-31.89%-0.63
120.03%0.19
-114.58%-1.16
-669.34%-0.65
---0.48
---0.92
---0.54
---0.08
---7.05
----
----
----
----
Revenue
2745.00%11.38M
--8.72M
--5.42M
--0.00
--400.00K
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
250.00%3.50M
-100.00%0.00
-97.73%68.00K
--0.00
--1.00M
--346.00K
0.00%3.00M
-100.00%0.00
Net Profit
-118.55%-20.19M
-41.95%-17.07M
-120.17%-20.46M
82.95%-5.16M
1369.52%108.83M
61.91%-12.03M
43.99%-9.29M
-155.74%-30.27M
144.47%7.41M
-246.74%-31.58M
-1373.45%-16.59M
-24.80%-11.84M
-111.37%-16.65M
58.69%-9.11M
97.59%-1.13M
-34.64%-9.48M
48.19%-7.88M
-37.76%-22.04M
-194.94%-46.68M
2.67%-7.04M
Net Margin
-100.65%-177.43%
---195.81%
---377.49%
----
--27208.25%
----
----
----
----
----
----
----
---475.83%
----
---1655.88%
---2865.53%
----
----
----
----
Gross Margin
-36.70%63.30%
--69.08%
--80.74%
----
--100.00%
----
----
----
----
----
----
----
--100.00%
----
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
5.10%8.35%
-53.05%9.11%
-47.58%9.12%
-44.74%8.55%
-42.00%7.94%
-19.67%19.41%
--17.41%
--15.47%
--13.70%
--24.16%
----
----
----
----
----
----
----
----
----
----
Revenue
2745.00%11.38M
--8.72M
--5.42M
--0.00
--400.00K
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
250.00%3.50M
-100.00%0.00
-97.73%68.00K
--0.00
--1.00M
--346.00K
0.00%3.00M
-100.00%0.00
Operating profit
40.10%-13.65M
-16.76%-23.03M
-37.42%-22.91M
-56.52%-24.02M
-27.59%-22.79M
-37.66%-19.73M
-26.22%-16.67M
-35.39%-15.35M
-53.75%-17.86M
-19.04%-14.33M
-10.20%-13.21M
-20.83%-11.33M
-22.72%-11.62M
16.54%-12.04M
15.51%-11.99M
36.93%-9.38M
30.97%-9.47M
1.19%-14.42M
2.03%-14.19M
-138.03%-14.87M
Net Profit
-118.55%-20.19M
-41.95%-17.07M
-120.17%-20.46M
82.95%-5.16M
1369.52%108.83M
61.91%-12.03M
43.99%-9.29M
-155.74%-30.27M
144.47%7.41M
-246.74%-31.58M
-1373.45%-16.59M
-24.80%-11.84M
-111.37%-16.65M
58.69%-9.11M
97.59%-1.13M
-34.64%-9.48M
48.19%-7.88M
-37.76%-22.04M
-194.94%-46.68M
2.67%-7.04M
Current assets
-29.14%164.58M
107.65%182.99M
103.17%204.91M
91.85%216.13M
84.48%232.26M
32.07%88.12M
80.94%100.85M
96.73%112.66M
185.90%125.90M
55.74%66.72M
4.97%55.74M
124.59%57.26M
45.36%44.04M
9.28%42.84M
-4.16%53.10M
-62.45%25.50M
-61.59%30.30M
-55.75%39.20M
-43.32%55.40M
-35.06%67.91M
Total current liabilities
-28.13%24.81M
72.64%31.05M
78.27%29.57M
20.40%22.18M
104.93%34.52M
51.26%17.98M
23.58%16.59M
119.00%18.42M
78.42%16.84M
60.23%11.89M
72.54%13.42M
-33.24%8.41M
-31.02%9.44M
-39.86%7.42M
-53.20%7.78M
-52.40%12.60M
-67.31%13.69M
-69.79%12.34M
-60.38%16.62M
-31.66%26.47M
Total assets
-27.10%179.51M
99.76%198.49M
101.57%219.57M
91.63%231.09M
83.75%246.23M
32.79%99.36M
70.20%108.93M
82.47%120.59M
150.24%134.00M
40.27%74.83M
-0.33%64.00M
70.50%66.09M
19.75%53.55M
-3.31%53.34M
-19.31%64.21M
-67.43%38.76M
-65.78%44.72M
-60.99%55.17M
-47.36%79.59M
-25.32%119.02M
Total liabilities
-37.76%51.45M
-7.61%53.55M
-7.00%60.35M
-19.99%59.86M
36.03%82.66M
-30.75%57.97M
31.97%64.90M
69.85%74.82M
37.46%60.76M
141.90%83.71M
31.30%49.18M
88.66%44.05M
79.45%44.20M
45.83%34.60M
32.76%37.45M
-40.55%23.35M
-47.13%24.63M
-49.56%23.73M
-42.01%28.21M
-11.25%39.27M
Total equity
-21.71%128.06M
250.13%144.94M
261.60%159.22M
274.09%171.23M
123.34%163.58M
566.12%41.40M
196.99%44.03M
107.70%45.77M
683.75%73.24M
-147.39%-8.88M
-44.60%14.83M
42.98%22.04M
-53.48%9.35M
-40.40%18.74M
-47.91%26.76M
-80.67%15.41M
-76.11%20.09M
-66.69%31.44M
-49.90%51.38M
-30.72%79.74M
Net operating income
6.86%-17.50M
-7.62%-19.80M
-8.42%-17.95M
-73.18%-21.19M
-48.09%-18.78M
-26.58%-18.40M
-79.31%-16.56M
-112.91%-12.23M
-23.34%-12.68M
-23.79%-14.54M
34.00%-9.23M
15.39%-5.75M
-14.10%-10.28M
14.20%-11.74M
53.76%-13.99M
34.28%-6.79M
21.55%-9.01M
-0.75%-13.69M
-1779.32%-30.26M
3.44%-10.33M
Net investment
-89.94%15.69M
17.80%4.96M
-49.39%9.55M
-947.95%-64.63M
453.23%155.89M
153.90%4.21M
63.73%18.88M
67.10%-6.17M
-946.90%-44.13M
-453.55%-7.82M
145.59%11.53M
-1236.63%-18.74M
472.75%5.21M
105.67%2.21M
-416.16%-25.29M
-93.84%1.65M
-106.38%-1.40M
-88.53%1.07M
38.34%8.00M
483.84%26.76M
Net financing
-131.78%-3.33M
-132.83%-2.22M
-31.99%3.61M
1826.76%5.16M
-85.76%10.49M
-73.40%6.77M
-28.83%5.31M
-101.30%-299.00K
1013.39%73.68M
636100.00%25.44M
-82.54%7.47M
448.48%22.98M
274.99%6.62M
---4.00K
161.87%42.77M
2321.39%4.19M
-252.56%-3.78M
-100.00%0.00
544266.67%16.33M
--173.00K

FAQs

What is the total revenue of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its total revenue reached 5.82M, with a year-on-year change of 5.82M.

What are the current assets of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its current assets were 204.91M, with a year-on-year change of 103.17.

What are the total assets of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its total assets of Abeona Therapeutics Inc were 219.57M, with a year-on-year change of 101.57.

What are the total liabilities of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its total liabilities of Abeona Therapeutics Inc were 60.35M, with a year-on-year change of -7.00.

What is the total equity of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its total equity of Abeona Therapeutics Inc was 159.22M, with a year-on-year change of 261.60.

What is the net operating income of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its net operating income of Abeona Therapeutics Inc was -89.45M, with a year-on-year change of -39.30.

What is the net investment of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its net investment of Abeona Therapeutics Inc was 105.03M, with a year-on-year change of 367.66.

What is the net financing of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its net financing of Abeona Therapeutics Inc was 26.04M, with a year-on-year change of -74.99.

What is the Earnings Per Share (EPS) of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.34, with a year-on-year change of 186.58.

What is the net income of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its net income was 71.18M, with a year-on-year change of 211.69.

What is the debt-to-asset ratio of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 9.12, with a year-on-year change of -47.58.

What is the Return on Equity (ROE) of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 70.05, with a year-on-year change of 132.34.

What is the Return on Assets (ROA) of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 43.34, with a year-on-year change of 158.80.

What is the operating profit of Abeona Therapeutics Inc?

According to Abeona Therapeutics Inc's FY2025 earnings report, its operating profit was -89.45M, with a year-on-year change of -39.30.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.